Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey

Xiaolin Li,1,2 Ting Su,3 Hua Xiao,1 Peichun Gao,4 Chongxiang Xiong,1 Jinghua Liu,3 Hequn Zou1 1Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, People’s Republic of China; 2Department of Endocrinology, Hunan University of Medicine, Hua...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li X, Su T, Xiao H, Gao P, Xiong C, Liu J, Zou H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/1c57b2a065f44c4fbbd7765b4e8bf516
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c57b2a065f44c4fbbd7765b4e8bf516
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic high-density lipoprotein cholesterol
anti-inflammation
renal protection
sex difference
functional heterogeneity
Specialties of internal medicine
RC581-951
spellingShingle high-density lipoprotein cholesterol
anti-inflammation
renal protection
sex difference
functional heterogeneity
Specialties of internal medicine
RC581-951
Li X
Su T
Xiao H
Gao P
Xiong C
Liu J
Zou H
Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
description Xiaolin Li,1,2 Ting Su,3 Hua Xiao,1 Peichun Gao,4 Chongxiang Xiong,1 Jinghua Liu,3 Hequn Zou1 1Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, People’s Republic of China; 2Department of Endocrinology, Hunan University of Medicine, Huaihua 418000, Hunan, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China; 4School of Public Health, Southern Medical University, Guangzhou 510080, People’s Republic of ChinaCorrespondence: Jinghua LiuGuangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of ChinaTel +86 20 61648392Fax +86 20 61648231Email liujhua@smu.edu.cnHequn ZouDepartment of Nephrology, The Third Affiliated Hospital, Southern Medical University, 183 Zhongshan Dadao, Tianhe District, Guangzhou 510630, People’s Republic of ChinaTel +86 20 62784393Fax +86 20 62784399Email hequnzou@hotmail.comPurpose: To explore the association between the anti-inflammatory and renal protective roles of high-density lipoprotein cholesterol (HDL-c) and its different levels in type 2 diabetes mellitus (T2D), hypertension (HTN), and chronic kidney disease (CKD) and to lay a theoretical basis for precise, maximum-benefit HDL-c-raising therapy for patients with these diseases.Patients and Methods: A total of 2127 participants (195 with T2D, 618 with HTN, 162 with CKD, and 1152 controls) were selected and divided into four groups according to their baseline HDL-c level, namely, low HDL-c (L-HDL-c, ≤ 1.03 mmol/L), medium HDL-c (M-HDL-c, 1.04– 1.55 mmol/L), high HDL-c (H-HDL-c, 1.56– 2.05 mmol/L) and extremely high HDL-c (E-HDL-c, ≥ 2.06 mmol/L). Serum and morning urine samples were collected to analyze the correlation between high-sensitivity C-reactive protein (HsCRP), interleukin-6 (IL-6), urine n-acetyl-β-d-glucosidase (U-NAG), retinol binding protein (RBP), and cystatin c (Cys-C) levels with the HDL-c levels.Results: The HDL-c levels of patients with T2D, HTN and CKD were universally lower than those in the control group in both sexes (p< 0.05), while male patients also manifested a lower level of HDL-c than female patients. However, although they had lower values of the renal impairment index, female patients were found to have anomalously higher amounts of proinflammatory cytokines. In addition, the correlations between HsCRP and RBP levels and HDL-c levels were most significant in patients with HTN (p< 0.05), whereas in patients with T2D and CKD, such relevance was less significant.Conclusion: Existence of substantial differences in HDL-c levels between different types of disease and sex highlighted that a higher HDL level does not always predict a better clinical outcome of patients. Moreover, we found that both HsCRP and RBP correlated negatively with HDL-c in HTN patients, indicating that monitoring HsCRP and RBP may serve as indicators for therapeutic efficacy of HDL-c-raising medications in HTN patients.Keywords: high-density lipoprotein cholesterol, anti-inflammation, renal protection, sex difference, functional heterogeneity
format article
author Li X
Su T
Xiao H
Gao P
Xiong C
Liu J
Zou H
author_facet Li X
Su T
Xiao H
Gao P
Xiong C
Liu J
Zou H
author_sort Li X
title Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
title_short Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
title_full Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
title_fullStr Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
title_full_unstemmed Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
title_sort association of the hdl-c level with hscrp, il-6, u-nag, rbp and cys-c in type 2 diabetes mellitus, hypertension, and chronic kidney disease: an epidemiological survey
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/1c57b2a065f44c4fbbd7765b4e8bf516
work_keys_str_mv AT lix associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT sut associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT xiaoh associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT gaop associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT xiongc associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT liuj associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
AT zouh associationofthehdlclevelwithhscrpil6unagrbpandcyscintype2diabetesmellitushypertensionandchronickidneydiseaseanepidemiologicalsurvey
_version_ 1718394558328340480
spelling oai:doaj.org-article:1c57b2a065f44c4fbbd7765b4e8bf5162021-12-02T12:16:02ZAssociation of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey1178-7007https://doaj.org/article/1c57b2a065f44c4fbbd7765b4e8bf5162020-10-01T00:00:00Zhttps://www.dovepress.com/association-of-the-hdl-c-level-with-hscrp-il-6-u-nag-rbp-and-cys-c-in--peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Xiaolin Li,1,2 Ting Su,3 Hua Xiao,1 Peichun Gao,4 Chongxiang Xiong,1 Jinghua Liu,3 Hequn Zou1 1Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, People’s Republic of China; 2Department of Endocrinology, Hunan University of Medicine, Huaihua 418000, Hunan, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China; 4School of Public Health, Southern Medical University, Guangzhou 510080, People’s Republic of ChinaCorrespondence: Jinghua LiuGuangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of ChinaTel +86 20 61648392Fax +86 20 61648231Email liujhua@smu.edu.cnHequn ZouDepartment of Nephrology, The Third Affiliated Hospital, Southern Medical University, 183 Zhongshan Dadao, Tianhe District, Guangzhou 510630, People’s Republic of ChinaTel +86 20 62784393Fax +86 20 62784399Email hequnzou@hotmail.comPurpose: To explore the association between the anti-inflammatory and renal protective roles of high-density lipoprotein cholesterol (HDL-c) and its different levels in type 2 diabetes mellitus (T2D), hypertension (HTN), and chronic kidney disease (CKD) and to lay a theoretical basis for precise, maximum-benefit HDL-c-raising therapy for patients with these diseases.Patients and Methods: A total of 2127 participants (195 with T2D, 618 with HTN, 162 with CKD, and 1152 controls) were selected and divided into four groups according to their baseline HDL-c level, namely, low HDL-c (L-HDL-c, ≤ 1.03 mmol/L), medium HDL-c (M-HDL-c, 1.04– 1.55 mmol/L), high HDL-c (H-HDL-c, 1.56– 2.05 mmol/L) and extremely high HDL-c (E-HDL-c, ≥ 2.06 mmol/L). Serum and morning urine samples were collected to analyze the correlation between high-sensitivity C-reactive protein (HsCRP), interleukin-6 (IL-6), urine n-acetyl-β-d-glucosidase (U-NAG), retinol binding protein (RBP), and cystatin c (Cys-C) levels with the HDL-c levels.Results: The HDL-c levels of patients with T2D, HTN and CKD were universally lower than those in the control group in both sexes (p< 0.05), while male patients also manifested a lower level of HDL-c than female patients. However, although they had lower values of the renal impairment index, female patients were found to have anomalously higher amounts of proinflammatory cytokines. In addition, the correlations between HsCRP and RBP levels and HDL-c levels were most significant in patients with HTN (p< 0.05), whereas in patients with T2D and CKD, such relevance was less significant.Conclusion: Existence of substantial differences in HDL-c levels between different types of disease and sex highlighted that a higher HDL level does not always predict a better clinical outcome of patients. Moreover, we found that both HsCRP and RBP correlated negatively with HDL-c in HTN patients, indicating that monitoring HsCRP and RBP may serve as indicators for therapeutic efficacy of HDL-c-raising medications in HTN patients.Keywords: high-density lipoprotein cholesterol, anti-inflammation, renal protection, sex difference, functional heterogeneityLi XSu TXiao HGao PXiong CLiu JZou HDove Medical Pressarticlehigh-density lipoprotein cholesterolanti-inflammationrenal protectionsex differencefunctional heterogeneitySpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 3645-3654 (2020)